Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for ...

The most negatively impacted sectors are frozen, refrigerated, general food and beverages. Circana found GLP-1 users’ monthly ...

LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without ...

Verdiva said this drug could be also be used as a monotherapy or in combination with a proprietary GLP-1 peptide drug. Other companies are also developing amylin-targeting drugs. Novo Nordisk’s ...

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

Stifel analyst Annabel Samimy initiated coverage of Altimmune (ALT) with a Buy rating and $18 price target The company is developing ...

Annabel Samimy, an analyst from Stifel Nicolaus, has initiated a new Buy rating on Altimmune (ALT).Stay Ahead of the Market:Discover ...